Machine Learning in Pharmaceutical Segmentation
The market is segmented by application into electronic recordkeeping, data integrity, predictive analysis, radiology, and others, out of which, the predictive analysis segment is anticipated to hold the notable share in the market over the forecast period owing to the dire need to predict the biological response of the patient to a certain drug, in order to design better treatment method for the disease. Machine learning can analyze data and overtime predict the possible outcomes. This is estimated to boost the growth of the segment.
Our in-depth analysis of the global market includes the following segments:
|
Application |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Machine Learning in Pharmaceutical Market size is set to register remarkable growth rate during the forecast period i.e., between 2025-2037.
Increasing adoption of artificial intelligence, and growing need for advanced technology in medical sector to boost the market growth.
North America industry is estimated to dominate majority revenue share by 2037, owing to the presence of major pharmaceutical companies in the region, along with constant advancements in the medical sector.
The major players in the market are Cyclica Inc., BioSymetrics Inc., Cloud Pharmaceuticals, Inc., Deep Genomics, Atomwise Inc., Alphabet Inc., and others.
